110 related articles for article (PubMed ID: 27076235)
1. [Malignant lymphoma].
Kato H; Kinoshita T
Rinsho Ketsueki; 2016 Mar; 57(3):249-59. PubMed ID: 27076235
[TBL] [Abstract][Full Text] [Related]
2. New targeted therapies for malignant lymphoma based on molecular heterogeneity.
Horn H; Staiger AM; Ott G
Expert Rev Hematol; 2017 Jan; 10(1):39-51. PubMed ID: 27918211
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways in lymphoma: pathogenesis and therapeutic targets.
Arita A; McFarland DC; Myklebust JH; Parekh S; Petersen B; Gabrilove J; Brody JD
Future Oncol; 2013 Oct; 9(10):1549-71. PubMed ID: 24106904
[TBL] [Abstract][Full Text] [Related]
4. Molecular deregulation of signaling in lymphoid tumors.
Spina V; Martuscelli L; Rossi D
Eur J Haematol; 2015 Oct; 95(4):257-69. PubMed ID: 25881749
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.
Maxwell SA; Mousavi-Fard S
Exp Biol Med (Maywood); 2013 Sep; 238(9):971-90. PubMed ID: 23986223
[TBL] [Abstract][Full Text] [Related]
6. [Molecular target drugs for malignant lymphoma].
Terui Y
Nihon Rinsho; 2010 Oct; 68(10):1881-8. PubMed ID: 20954334
[TBL] [Abstract][Full Text] [Related]
7. B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies.
Puri KD; Di Paolo JA; Gold MR
Int Rev Immunol; 2013 Aug; 32(4):397-427. PubMed ID: 23886342
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies for B-cell non-Hodgkin lymphoma.
Briones J
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1305-16. PubMed ID: 19761434
[TBL] [Abstract][Full Text] [Related]
9. Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma.
Blachly JS; Baiocchi RA
Br J Haematol; 2014 Oct; 167(1):19-32. PubMed ID: 25100567
[TBL] [Abstract][Full Text] [Related]
10. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
Seda V; Mraz M
Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls of Combining Novel Agents in Lymphoma.
Rodgers TD; Barr PM
Curr Treat Options Oncol; 2018 May; 19(7):35. PubMed ID: 29808236
[TBL] [Abstract][Full Text] [Related]
12. The role of the ubiquitin proteasome system in lymphoma.
Suh KS; Tanaka T; Sarojini S; Nightingale G; Gharbaran R; Pecora A; Goy A
Crit Rev Oncol Hematol; 2013 Sep; 87(3):306-22. PubMed ID: 23541070
[TBL] [Abstract][Full Text] [Related]
13. Genomic alterations underlying immune privilege in malignant lymphomas.
Mottok A; Steidl C
Curr Opin Hematol; 2015 Jul; 22(4):343-54. PubMed ID: 26049756
[TBL] [Abstract][Full Text] [Related]
14. Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma.
Waibel M; Gregory G; Shortt J; Johnstone RW
Curr Opin Hematol; 2014 Jul; 21(4):297-308. PubMed ID: 24811162
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
Mato A; Jauhari S; Schuster SJ
Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792
[TBL] [Abstract][Full Text] [Related]
16. [Diffuse large B-cell lymphoma: therapeutic development based on clinical and biological heterogeneity].
Miyazaki K
Rinsho Ketsueki; 2015 Oct; 56(10):2047-55. PubMed ID: 26458444
[TBL] [Abstract][Full Text] [Related]
17. Beyond chemotherapy: new agents for targeted treatment of lymphoma.
Younes A
Nat Rev Clin Oncol; 2011 Feb; 8(2):85-96. PubMed ID: 21151205
[TBL] [Abstract][Full Text] [Related]
18. Targeting histones and proteasomes: new strategies for the treatment of lymphoma.
O'Connor OA
J Clin Oncol; 2005 Sep; 23(26):6429-36. PubMed ID: 16155030
[TBL] [Abstract][Full Text] [Related]
19. New drugs for aggressive B-cell and T-cell lymphomas.
Murawski N; Pfreundschuh M
Lancet Oncol; 2010 Nov; 11(11):1074-85. PubMed ID: 21051020
[TBL] [Abstract][Full Text] [Related]
20. [New treatments of malignant lymphoma--a review].
Mark M; Cerny T
Ther Umsch; 2010 Oct; 67(10):537-43. PubMed ID: 20886460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
